Clinical Oversight & Safety Licensed providers (may include video consultations, not just asynchronous) Partner compounding pharmacies comply with USP 795 and USP 797 safety standards The 2-month minimum commitment is non-negotiable
Factor in consultation fees, monitoring requirements, and potential combination protocols
Yeh C-T, Ching L-C, Yen G-C
Doctors recommend pumping the brakes before assuming that GLP-1s will become the next big thing in treatment for depression and anxiety
It will be interesting to see how orforglipron compares to other oral contenders like danuglipron and next-gen semaglutide
Given the difficulty of targeting endothelial cells in the dermis, inhibiting downstream pathways activating melanocytes, like EDN-1/EDN receptor signaling [176,177,178,179], could be particularly relevant for treating melasma and solar lentigo as this signaling pathway is upregulated in these conditions [180]